Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Medical Industry Today.
Press releases published on April 17, 2025
Olon erhält CMO Excellence in Green Chemistry Award 2025
GlobeNewswire
·
April 17, 2025
RODANO, Italien, April 17, 2025 (GLOBE NEWSWIRE) -- Olon S.p.A. freut sich, die Verleihung des renommierten CMO Excellence in Green Chemistry Award 2025 bekanntzugeben. Diese Auszeichnung, die vom ACS Green Chemistry Institute Pharmaceutical Roundtable ( …
Olon se voit décerné le Prix d’excellence CMO en chimie verte en 2025
GlobeNewswire
·
April 17, 2025
RODANO, Italie, 17 avr. 2025 (GLOBE NEWSWIRE) -- Olon S.p.A. a l’honneur d’annoncer qu’elle a reçu le prestigieux Prix d’excellence CMO en chimie verte (CMO Excellence in Green Chemistry Award) en 2025. Décernée par l’ACS Green Chemistry Institute …
Victoza Weight Loss: Buy OTC Victoza For Weight Loss Medication Alternative From PhenQ – Real Reviews
GlobeNewswire
·
April 17, 2025
Albany, New York, April 17, 2025 (GLOBE NEWSWIRE) -- In thе last 30 yеars and thе Amеricas havе witnеssеd a significant surgе in adults diagnosеd with diabеtеs and attributеd to еscalatin ratеs of obеsity and poor diеtary habits and and sеdеntary …
Clearmind Medicine Receives Notice of Allowance for United States Patent Covering Binge Behavior
GlobeNewswire
·
April 17, 2025
Vancouver, Canada, April 17, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
Best Berberine Supplement: Top Berberine Supplements For Weight Loss & Blood Sugar From Sugar Defender
GlobeNewswire
·
April 17, 2025
Albany, New York, April 17, 2025 (GLOBE NEWSWIRE) -- What is Berberine? Berberine is an alkaloid found in plants, such as barberry. Traditional Asian medicines have long recognized the health advantages of this alkaloid. Berberine has gained popularity as …
Zevra Announces Publication of MIPLYFFA® Mechanism of Action Manuscript in Molecular Genetics and Metabolism
GlobeNewswire
·
April 17, 2025
CELEBRATION, Fla., April 17, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announces the publication of “ …
Do Probiotics Make You Poop? Probiotic & Prebiotic Supplement For Constipation From YourBiology
GlobeNewswire
·
April 17, 2025
Albany, New York, April 17, 2025 (GLOBE NEWSWIRE) -- Some cultured foods and the living bacteria and yeasts present naturally in the human body may aid in gastrointestinal health maintenance. Do Probiotics Make You Poop? What to Know On the other hand, …
Injectable Drug Delivery Devices Market Set to Reach $317.2 Billion by 2029
GlobeNewswire
·
April 17, 2025
Boston, April 17, 2025 (GLOBE NEWSWIRE) -- BCC Research reveals in its new report, Global Injectable Drug Delivery Devices Market, the market for injectable drug delivery devices is projected to grow to $317.2 billion by 2029 at a five-year compound annual …
uniQure Announces FDA Breakthrough Therapy Designation Granted to AMT-130 for the Treatment of Huntington’s Disease
GlobeNewswire
·
April 17, 2025
~ Breakthrough Therapy designation based on clinical evidence from Phase I/II trials showing meaningful slowing of disease progression ~ ~ Additional regulatory update and guidance on the Biologics License Application submission expected in the second …
Amwell® to report first quarter 2025 operating results
GlobeNewswire
·
April 17, 2025
BOSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in digital care, will report first quarter 2025 operating results after stock market trading hours on Thursday, May 1 2025. Following the distribution of the earnings alert via wire …
EYLEA HD® (aflibercept) Injection 8 mg sBLA Accepted for FDA Priority Review for Both the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing in Approved Indications
GlobeNewswire
·
April 17, 2025
If approved, EYLEA HD would be the first and only treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period – halving the number of injections that are indicated for all other anti-VEGF therapies Potential for as …
Agios to Webcast Conference Call of First Quarter Financial Results on May 1, 2025
GlobeNewswire
·
April 17, 2025
CAMBRIDGE, Mass., April 17, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced the company will host a conference …
New Study Reveals Promise of Text-Based Mental Health Support App Counslr in Decreasing Barriers to Mental Health Support
GlobeNewswire
·
April 17, 2025
NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Counslr, a leading B2B mental health and wellness platform, announced today the publication of a new study in JMIR Formative Research titled “Evaluating User Engagement with a Real-Time, Text-Based Digital …
Tilray Brands Announces Proposed Reverse Stock Split and Corresponding Special Meeting of Stockholders
GlobeNewswire
·
April 17, 2025
NEW YORK and LEAMINGTON, Ontario, April 17, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness …
Enovis to Host First Quarter 2025 Results Conference Call on May 8th
GlobeNewswire
·
April 17, 2025
Wilimington, DE, April 17, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its first quarter 2025 …
Atea Pharmaceuticals Appoints Howard H. Berman to Board of Directors and Announces Share Repurchase Program
GlobeNewswire
·
April 17, 2025
BOSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea” or “Company”), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today …
Bright Peak Therapeutics Appoints John Schmid to its Board of Directors
GlobeNewswire
·
April 17, 2025
SAN DIEGO and BASEL, Switzerland , April 17, 2025 (GLOBE NEWSWIRE) -- Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional immunotherapies for cancer, today announced the appointment of John …
AAFA Announces Innovative Program in Texas Serving Communities Facing Highest Rates of Asthma
GlobeNewswire
·
April 17, 2025
Washington, DC, April 17, 2025 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) announces an innovative new collaboration with Health Care Originals, Inc. (HCO) and Rabbit Air as part of AAFA’s Health Equity Advancement and …
Nurix Announces FDA Clearance of IND Application for GS-6791/NX-0479 - a Novel IRAK4 Degrader for Inflammatory Conditions
GlobeNewswire
·
April 17, 2025
Collaboration partner, Gilead Sciences, to begin Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) study in healthy volunteers in Q2 2025 GS-6791/NX-0479 has potential clinical applications across multiple blockbuster markets in …
Ostarine (MK 2866) PCT: Ostarine Before & After Result Benefits - Legal Ostarine MK-2866 SARM For Sale From CrazyBulk
GlobeNewswire
·
April 17, 2025
Albany, New York, April 17, 2025 (GLOBE NEWSWIRE) -- Ostarine, also known as MK-2866, is a SARM that is considered to be on the milder end of the spectrum and is often used by novices. Many people take this to mean that you do not need to complete the PCT …